These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24952867)

  • 1. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin.
    Kenaan M; Seth M; Aronow HD; Wohns D; Share D; Gurm HS;
    J Am Coll Cardiol; 2013 Dec; 62(22):2083-9. PubMed ID: 24055844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
    Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of percutaneous coronary intervention following recent surgery.
    Hoyt JR; Seth M; Hanson I; Dixon S; Share D; Lalonde T; Wohns D; Moscucci M; Gurm HS
    Am J Cardiol; 2013 Nov; 112(10):1580-5. PubMed ID: 23998350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.
    Ko DT; Wijeysundera HC; Yun L; Austin PC; Cantor WJ; Tu JV
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):459-66. PubMed ID: 21712520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
    Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
    Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
    Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery.
    Argalious M; Xu M; Sun Z; Smedira N; Koch CG
    Anesth Analg; 2010 Aug; 111(2):324-30. PubMed ID: 20375302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of inflammation and benefit of statins after percutaneous coronary interventions.
    Chan AW; Bhatt DL; Chew DP; Reginelli J; Schneider JP; Topol EJ; Ellis SG
    Circulation; 2003 Apr; 107(13):1750-6. PubMed ID: 12665489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.